Hoey Investments, Inc Crispr Therapeutics Ag Transaction History
Hoey Investments, Inc
- $505 Million
- Q1 2025
A detailed history of Hoey Investments, Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Hoey Investments, Inc holds 100 shares of CRSP stock, worth $3,782. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$3,782% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
482Shares Held
64.2MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$339 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$331 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$144 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$105 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$104 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.95B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....